Browse resources

Region: Global

Total results with these characteristics: 934

The Emerging Adolescent Agenda: HPV Vaccine, AIDS Prevention Research, and the New Opportunities for Reaching the Young People of the World

This chapter from an annual report explores why licensure of the vaccine against human papillomavirus (HPV) presents the AIDS vaccine field with new opportunities. The report discusses how to advocate for financing commitments to ensure widespread …

Author: AIDS Vaccine Advocacy Coalition

Published: 2006

Enhanced Pulmonary Histopathology is Observed in Cotton Rats Immunized with Formalin-Inactivated Respiratory Syncytial Virus (RSV) or Purified F Glycoprotein and Challenged With RSV 3-6 Months After Immunization

The authors of this study, published in Vaccine, compared formalin-inactivated (FI) RSV, purified F glycoprotein in alum, and RSV infection (intranasal) for their immunogenicity, efficacy, and ability to enhance pulmonary histopathology during RSV …

Author: Murphy BR, Sotnikov AV, Lawrence LA, Banks SM, Prince GA

Published: 1990

Ensuring Access to HPV Vaccines Through Integrated Services: A Reproductive Health Perspective

This article, published in the Bulletin of the World Health Organization, describes avenues for service delivery of human papillomavirus (HPV) vaccines and critical information gaps that must be bridged in order to inform future sexual and …

Author: Pollack AE, Balkin M, Edouard L, Cutts F, and Broutet N on behalf of the WHO/United Nations Population Fund Working Group on Sexual and Reproductive Health and HPV Vaccines

Published: 2007

Ensuring That Developing Countries Have Access to New Healthcare Products: The Role of Product Development Partnerships

According to this article published in the eJournal Innovation Strategies Today, product development partnerships (PDPs) are generating an increasing flow of health products, including vaccines, for diseases prevalent in developing countries. …

Author: Brooks AD, Wells WA, McLean TD, et al.

Published: 2010

Enteric Diseases

This web page provides information in enteric diseases, including NIAID-supported research, meeting summaries, news releases, and resources for researchers.

Author: US National Institute for Allergy and Infectious Diseases (NIAID)

Enteric Infections and the Vaccines to Counter Them: Future Directions

Published in the journal Vaccine, this article discusses the importance of creating reliable, long-term demand for the next generation of enteric vaccines, including new rotavirus, Shigella, and ETEC vaccines and priorities for achieving this …

Author: Levine M

Published: 2006

Enteric Infections, Diarrhea, and Their Impact on Function and Development

Enteric infections, with or without overt diarrhea, have profound effects on intestinal absorption, nutrition, and childhood development as well as on global mortality. Oral rehydration therapy has reduced the number of deaths from dehydration …

Author: Petri Jr. WA, Miller M, Binder HJ, et al.

Published: 2008

Enterotoxigenic Escherichia coli: Advances in Technical and Laboratory Aspects of Research and Development of Vaccines

From the Weekly Epidemiological Record, this report is from an international consultative meeting on ETEC to examine the most recent epidemiological data from the field, identify gaps in the laboratory methods for strain …

Author: World Health Organization

Published: 2008

Enterotoxigenic Escherichia coli (ETEC)

This web page provides information on ETEC, its transmission, prevention of the disease, and more.

Author: US Centers for Disease Control and Prevention

Epidemiology, Aetiology and Management of Childhood Acute Community-Acquired Pneumonia in Developing Countries--A Review

This article, published in the African Journal of Medicine and Medical Sciences, provides an overview of the causes of clinical pneumonia in developing countries, available vaccines for fighting pneumonia, and efforts underway and planned to expand …

Author: Falade AG, Ayede AI

Published: 2011

Epidemiology of Japanese encephalitis in Context With Indian Scenario

This article provides a historical overview of Japanese encephalitis (JE) in India since the first detection of JE virus activity in 1952 until the 2006 introduction of JE vaccine in high-risk states and expansion of vaccination efforts in …

Author: Dhillon GP, Raina VK

Published: 2008

The Epidemiology of JE

This slide presentation gives an overview of the epidemiology of JE and can be adapted for individual use.

Author: PATH

Published: 2007

The Epidemiology of Meningococcal Disease and the Impact of Vaccines

Neisseria meningitidis causes meningococcal disease, a severe bacterial infection of the bloodstream or meninges, worldwide. The disease is most common among young children, but the existing polysaccharide vaccines have been sparsely used because …

Author: Khatami A, Pollard AJ

Published: 2010

Escherichia coli Infections

This web page provides general information on Escherichia coli bacteria and symptoms of disease. It also includes links to other World Health Organization web pages related to E. coli.

Author: World Health Organization

Essential Training Package for HPV Vaccine Introduction for Countries Introducing Cervarix™ 2 Dose Vaccine

These eight training modules relate to key aspects of the introduction of the human papillomavirus (HPV) vaccine Cervarix™. They are intended for use by health workers during vaccine introduction training sessions and contain facilitator notes …

Author: World Health Organization

Published: 2013

Establishment of a New Human Pneumococcal Standard Reference Serum 007sp

This article, published in Clinical and Vaccine Immunology, reports on a study that resulted in the development of a new pneumococcal reference serum to replace the dwindling stocks of Lot 89SF, the reference standard serum pool used since 1990. The …

Author: Goldblatt D, Plikaytis BD, Akkoyunlu M, et al.

Published: 2011

Estimated Global Mortality Associated With the First 12 Months of 2009 Pandemic Influenza A H1N1 Virus Circulation: A Modelling Study

This article, published in The Lancet Infectious Diseases, estimates the global mortality associated with the first 12 months of the 2009 influenza A/H1N1 virus pandemic. Results of the analysis estimate that respiratory and cardiovascular …

Author: Dawood FS, Iuliano AD, Reed C, et al.

Published: 2012

Estimated Hib and Pneumococcal Deaths for Children Under 5 Years of Age, 2008

This web page provides an estimate of child mortality due to Haemophilus influenzae type b (Hib) and pneumococcal infections in 2008. It also contains a link to a chart of death rates due to these infections, broken down by region and HIV status.

Author: World Health Organization

Published: 2013

Estimates of World-Wide Distribution of Child Deaths From Acute Respiratory Infections

To establish a relation between deaths due to acute respiratory infections (ARI) and all-cause deaths in children under 5 years we show that the proportion of deaths directly attributable to ARI declines from 23% to 18% and then 15% (95% confidence …

Author: Williams B, Gouws E, Boschi-Pinto C, Bryce J, Dye C

Published: 2002

Estimating Age-Specific Cumulative Incidence for the 2009 Influenza Pandemic: A Meta-analysis of A(H1N1)pdm09 Serological Studies From 19 Countries

This article, published in Influenza and Other Respiratory Viruses, details the results of a meta-analysis conducted to provide insights into the global impact of the 2009 influenza A(H1N1) pandemic. The study estimates overall and age-specific …

Author: Van Kerkhove MD, Hirve S, Koukounari A, Mounts AW

Published: 2013

Estimating the Burden of Pneumococcal Pneumonia Among Adults: A Systematic Review and Meta-Analysis of Diagnostic Techniques

This article, published in PLOS One, summarizes a study to develop a conceptual and quantitative strategy for estimating the non-bacteremic disease burden among adults with community-acquired pneumonia. The authors conclude that the adult burden of …

Author: Said MA, Johnson HL, Nonyane BAS, Deloria-Knoll M, O′Brien KL

Published: 2013

Estimating the Costs of Achieving the WHO-UNICEF Global Immunization Vision and Strategy, 2006 - 2015

This paper estimates the costs of achieving the Global Immunization Vision and Strategy, 2006 - 2015, which aims to immunize more people, from infants to seniors, with a greater range of vaccines, and whose chief goal is to, by 2015 or earlier, …

Author: Wolfson LJ, Gasse F, Lee-Martin S, et al.

Published: 2008

Estimating the Protective Concentration of Anti-pneumococcal Capsular Polysaccharide Antibodies

Published in the journal Vaccine, this article describes a method for correlating pneumococcal anticapsular antibody responses of infants immunized with pneumococcal conjugate (PnC) vaccine (Prevenar) with clinical protection from invasive …

Author: Siber G, Chang I, Baker S, et al.

Published: 2007

Estimation of the Potential Overall Impact of Human Papillomavirus Vaccination on Cervical Cancer Cases and Deaths

This article, published in Vaccine, reports on a study that aimed to estimate the potential real-life impact of the AS04-adjuvanted HPV-16/18 vaccine on cervical cancer cases and deaths at the country level. The authors found that HPV vaccination …

Author: Van Kriekinge G, Castellsagué X, Cibula D, Demarteau N

Published: 2014

Evaluating Clinical Trial Data and Guiding Future Research for Rotavirus Vaccines

This article, published in the Weekly Epidemiological Record, discusses the outcome of a meeting of global, regional, and country-level rotavirus experts and immunization opinion leaders who gathered to provide guidance on evaluating and …

Author: World Health Organization

Published: 2008